D‐β‐hydroxybutyrate protects dopaminergic SH‐SY5Y cells in a rotenone model of Parkinson's disease
- 17 August 2006
- journal article
- Published by Wiley in Journal of Neuroscience Research
- Vol. 84 (6), 1376-1384
- https://doi.org/10.1002/jnr.21021
Abstract
It has been postulated that the pathogenesis of Parkinson's disease (PD) is associated with mitochondrial dysfunction. Rotenone, an inhibitor of mitochondrial complex I, provides models of PD both in vivo and in vitro. We investigated the neuroprotective effect of D‐β‐hydroxybutyrate (bHB), a ketone body, against rotenone toxicity by using SH‐SY5Y dopaminergic neuroblastoma cells. SH‐SY5Y cells, differentiated by all‐trans‐retinoic acid, were exposed to rotenone at concentrations ranging from 0 to 1,000 nM. We evaluated cellular oxidation reduction by the alamarBlue assay, viability by lactate dehydrogenase (LDH) assay, and survival/death ratio by live/dead assays. Exposure to rotenone for 48 hr oxidized cells and decreased their viability and survival rate in a concentration‐dependent manner. Pretreatment of cells with 8 mM bHB provided significant protection to SH‐SY5Y cells. Whereas rotenone caused the loss of mitochondrial membrane potential, released cytochrome c into the cytosol, and reduced cytochrome c content in mitochondria, addition of bHB blocked this toxic effect. bHB also attenuated the rotenone‐induced activation of caspase‐9 and caspase‐3. Administration of 0–10 mM 3‐nitropropionic acid, a complex II inhibitor, also decreased the reducing power of SH‐SY5Y cells measured by alamarBlue assay. Pretreatment with 8 mM bHB attenuated the decrease of alamarBlue fluorescence. These data demonstrated that bHB had a neuroprotective effect that supported the mitochondrial respiration system by reversing the inhibition of complex I or II. Ketone bodies, the alternative energy source in the mammalian brain, appear to have therapeutic potential in PD.Keywords
This publication has 39 references indexed in Scilit:
- Novel cytoprotective mechanism of anti-parkinsonian drug deprenyl: PI3K and Nrf2-derived induction of antioxidative proteinsBiochemical and Biophysical Research Communications, 2006
- The Energetics of Ion Distribution: The Origin of the Resting Electric Potential of CellsIUBMB Life, 2002
- Analysis of mitochondrial morphology and function with novel fixable fluorescent stains.Journal of Histochemistry & Cytochemistry, 1996
- Generation of Ketone Bodies from Leucine by Cultured Astroglial CellsJournal of Neurochemistry, 1995
- L‐Dihydroxyphenylalanine and complex I deficiency in Parkinson's disease brainMovement Disorders, 1995
- β/A4‐evoked degeneration of differentiated SH‐SY5Y human neuroblastoma cellsJournal of Neuroscience Research, 1994
- Fatty Acid Oxidation and Ketogenesis by Astrocytes in Primary CultureJournal of Neurochemistry, 1991
- Mitochondrial Complex I Deficiency in Parkinson's DiseaseJournal of Neurochemistry, 1990
- Retinoic acid-induced differentiation of cultured human neuroblastoma cells: a comparison with phorbolester-induced differentiationCell Differentiation, 1984
- BASAL GANGLIA DEGENERATION, MYELIN ALTERATIONS, AND ENZYME INHIBITION INDUCED IN MICE BY THE PLANT TOXIN 3‐NITROPROPANOIC ACIDNeuropathology and Applied Neurobiology, 1982